Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
May 07 2024 - 7:00AM
Integer Holdings Corporation (NYSE: ITGR), a leading medical device
contract development and manufacturing organization (CDMO), will
join medtech industry leaders around the world in exhibiting at
Heart Rhythm 2024, a Heart Rhythm Society (HRS) educational event
and exhibition in Boston from May 16 – 19, 2024.
HRS attendees are invited to visit Integer at booth #753 to
learn more about the company’s comprehensive end-to-end solutions,
designed to help customers accelerate time to market, strengthen
innovation, simplify supply chain and confidently scale production
across a globally competitive network of locations.
Some examples include market-leading battery technology,
finished leads and implantable pulse generators (IPG) for cardiac
applications. Integer is a leading manufacturer of access and
complex catheter access solutions in electrophysiology, including
guidewires, transseptal access, diagnostic and ablation technology
platforms.
Those attending HRS will discover how Integer’s recent strategic
investments, particularly the acquisition of Pulse Technologies,
are reshaping how Integer serves the world’s leading medical device
OEMs and start-ups. Pulse Technologies, based in Quakertown,
Pennsylvania, brings unmatched precision machining and patented
technologies such as Hierarchical Surface Restructuring (HSR™)
coatings to Integer’s portfolio. These innovations significantly
enhance the performance and reliability of medical devices across
cardiac rhythm management, neuromodulation, and cardiovascular
applications. HSR enhances electrodes and microelectrode arrays
using a proprietary ultra-short pulse laser-based process,
supporting a range of applications.
“The integration of Pulse Technologies’ advanced surface
texturing and coating technologies into Integer’s services empowers
the development of specialized components that offer superior
electrochemical performance and durability,” said Payman Khales,
President, Cardio & Vascular.
Khales added, “These capabilities allow Integer to support the
rapidly evolving needs of the medical device sector with innovative
solutions that significantly shorten time to market and enhance
patient care.”
Learn more about Integer at www.integer.net.
About Integer®Integer Holdings
Corporation (NYSE:ITGR) is one of the largest medical device
contract development and manufacturing organizations (CDMO) in the
world, serving the cardiac rhythm management, neuromodulation, and
cardio and vascular markets. As a strategic partner of choice to
medical device companies and OEMs, the Company is committed to
enhancing the lives of patients worldwide by providing innovative,
high-quality products and solutions. The Company's brands include
Greatbatch Medical®, Lake Region
Medical® and Electrochem®.
Additional information is available at www.integer.net.
Investor Relations:Andrew
Sennandrew.senn@integer.net763.951.8312 |
Media
Relations:Kelly
Butlerkelly.butler@integer.net469.731.6617 |
Integer (NYSE:ITGR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Integer (NYSE:ITGR)
Historical Stock Chart
From Sep 2023 to Sep 2024